BIOBRIEFPAPER
Anchoring a two part polymer to one site on an oncolytic adenovirus shifted the virus from liver to tumor in pre immunized mice and kept it infectious despite neutralizing antibodies.
Most polymer coats for cancer-killing viruses try to hide them from the immune system. This one tries something else: changing where the virus ends up.
In a 2026 paper in the Journal of Controlled Release, researchers describe PEPB, the coated version of the oncolytic adenovirus AdNuPARc-E, a virus engineered to replicate inside tumor cells. The coat is a two-part polymer, a bioresponsive oligopeptide-modified poly(β-aminoester) called OM-PBAE-CRRR paired with a linear PEG chain, anchored to a specific spot on the virus's outer protein shell called the hexon hypervariable region 1, rather than sprayed across the whole capsid. The work is in cell cultures and in mice, not humans.
In cell culture, the coated virus matched the uncoated virus's tumor-killing ability, with only a short early delay. The differences showed up in mice. In a pancreatic cancer xenograft, the coated construct circulated longer and transduced both liver and tumor more efficiently. In mice already exposed to the virus and carrying neutralizing antibodies, the standard roadblock for repeat-dose virus therapy, the coat kept the virus infectious and shifted where it accumulated, away from the liver and toward the tumor, with measurable antitumor activity.
The result is a delivery mechanism in mice, not a cure. But it shows a position-specific anchor can do two jobs at once, evading the antibodies that would normally trap the virus and redirecting the dose toward the tissue it is meant to hit.